ELK1 and cancer: In the absence of NK1R, the matrix _02 had a predominant participation driving 8 transcripts, which includes those involved in cancer (EYA1, Trail, HSF, and ELK-1), smooth-to-skeletal muscle trans-differentiation, and Z01, a tight-junction protein, expression (Table 3, [additional file 3]).